3BBLACKBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
3B BlackBio Dx Limited held its 53rd AGM on September 26, 2025, via video conferencing. All 10 resolutions were passed with overwhelming majority (over 99.99% in favour on most items). Key items approved include: adoption of audited standalone and consolidated financial statements for FY25, declaration of a 40% dividend (₹4 per equity share), re-appointment of Mr. Dhirendra Dubey as Chairman-cum-Managing Director, revision in remuneration for Mr. Dhirendra Dubey and Mr. Nikhil Kuber Dubey (WTD cum CFO), re-appointment of Mrs. Mithla Dubey, appointment of Secretarial Auditors, ratification of Cost Auditor remuneration of ₹50,000, and regularization of Mr. Vivek Sehgal as Independent Director. Total voting participation was 60.83% (52.2 lakh votes polled out of 85.8 lakh outstanding shares), with promoters polling 93.18% of their holding and public shareholders 38.08%.
Shareholders have approved a ₹4 per share dividend (40%) for FY25, reflecting healthy returns. Approval of director remuneration revisions and re-appointments signals management continuity. All resolutions passed with near-unanimous support, indicating strong shareholder confidence. No contentious issues observed — unlikely to materially move the stock price.